Smart wearable could predict COPD Flare-Ups before they happen

NCT ID NCT05655832

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a wearable device (Vivalink) could track health signs like heart rate, breathing, and activity in people with COPD. 77 participants wore the device for 3 months to see if the data could predict when symptoms would get worse. The goal was to find a way to monitor COPD at home and catch flare-ups early.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Vivalink wearable device
What this could lead to
If successful, this could lead to a way for people with COPD to monitor their condition at home and get early warnings of worsening symptoms.
What could go wrong
This was a small, completed study that only looked at whether the device data matches standard measures. It does not prove the device can prevent or treat COPD flare-ups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PULMONARY DISEASE, CHRONIC OBSTRUCTIVE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Lungenpraxis Dr. Franz / Dr. Weber

    Witten, Germany

  • Lungenzentrum Darmstadt GmbH

    Darmstadt, Germany

  • Lungenzentrum Frankfurt

    Frankfurt, Germany

  • Pneumologische Gemeinschaftspraxis Saarbrücken

    Saarbrücken, Germany

  • Pneumologische Praxis Wiesbaden

    Wiesbaden, Germany

  • Pneumologisches Studienzentrum München-West

    München, Germany

  • Praxis an der Oper

    Berlin, Germany

  • RespiRatio / Lungenpraxis

    Schleswig, Germany

  • Städtische Kliniken Darmstadt

    Darmstadt, Germany

  • Thoraxklinik Heidelberg gGmbH

    Heidelberg, Germany

  • ZERO Praxen

    Mannheim, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.